FDA cleared the UNEEG EpiSight System from Uneeg Medical A/S on Jun 11, 2026 under K253607, a traditional 510(k). The device falls under product code SEM, Sub-Scalp Implanted Electroencephalogram System For Remote Patient Monitoring, regulated at 21 CFR 882.1360 as a Class 2 device. The review panel was Neurology.

FDA logged the submission as received on Nov 18, 2025. The decision came 205 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Uneeg Medical A/S in the last 12 months of the tracker.